Amisulpride treatment for clozapine-induced sialorrhea.
Praharaj
Samir Kumar
SK
Sarkar
Sukanto
S
Sinha
Vinod Kumar
VK
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D050637:Receptors, Dopamine D3 / Q000037:antagonists & inhibitors; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced* / Q000188:drug therapy; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D050637:Receptors, Dopamine D3; D013469:Sulpiride; D000077582:Amisulpride; D003024:Clozapine